Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Zon RL, Berliner N. How I manage inpatient consultations for quantitative neutrophil abnormalities in adults. Blood.2023;142(9):786-793.

Publikováno v: Blood; November 2023, Vol. 142 Issue: 21 p1847-1847, 1p

Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a chemotherapy plus ATRA cohort from an international consortium.

Autor: Silva WF; Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo., Kim HT; Dana-Farber Cancer Institute, Boston., Undurraga MS; Hospital del Salvador, Providencia, Chile., Navarro-Cabrera JR; Edgardo Rebagliati Hospital, Jesus Maria, Peru., Salinas V; Instituto de Prevision Social, Asuncion, Paraguay., Muxi P; Hospital Britanico, Montevideo, Uruguay., Melo RAM; University of Pernambuco, Recife., Gloria ABF; Federal University of Minas Gerais, Belo Horizonte., Pagnano KBB; Universidade Estadual de Campinas, Campinas., Nunes EC; Federal University of Parana, Curitiba., Bittencourt RI; Hospital de Clinicas de Porto Alegre, Porto Alegre., Rojas N; Edgardo Rebagliati Hospital, Jesus Maria, Peru., Truyenque SMQ; Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Peru., Ayala-Lugo AI; Universidad Nacional de Asuncion, Asuncion, Paraguay., Oliver AC; Hospital Britanico, Montevideo, Uruguay., Figueiredo-Pontes LL; Ribeirao Preto Medical School, Ribeirao Preto., Traina F; Ribeirao Preto Medical School, Ribeirao Preto., Moreira F; Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo., Fagundes EM; Federal University of Minas Gerais, Belo Horizonte., Duarte BKL; Universidade Estadual de Campinas, Campinas., Mora-Alferez AP; Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Peru., Ortiz P; Edgardo Rebagliati Hospital, Jesus Maria, Peru., Untama JL; Edgardo Rebagliati Hospital, Jesus Maria, Peru., Tallman MS; Memorial Sloan Kettering Cancer Center, New York., Ribeiro RC; St. Jude Children's Research Hospital, Memphis., Ganser A; Hannover Medical School, Hannover., Dillon RJ; King's College, London., Valk PJM; Erasmus University Medical Center, Rotterdam., Sanz MA; Valencia University Medical School, Valencia., Löwenberg B; Erasmus University Medical Center, Rotterdam., Berliner N; Brigham and Women's Hospital, Boston., Rego EM; Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo. eduardo.rego@hc.fm.usp.br.

Publikováno v: Haematologica [Haematologica] 2024 Oct 31. Date of Electronic Publication: 2024 Oct 31.

Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.

Autor: AlJabban A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Paik H; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Enterprise Research IS (ERIS), Digital, Mass General Brigham, Boston, MA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Berliner N; Harvard Medical School, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Brouillard J; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Brown JR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Burns KH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA., Castillo JJ; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Card J; Department of Quality and Safety, Dana-Farber Cancer Institute, Boston, MA., Dal Cin P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., DeAngelo DJ; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Ebert BL; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Garcia JS; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jacobson CA; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lakhani H; Department of Quality and Safety, Dana-Farber Cancer Institute, Boston, MA., Laubach JP; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA., Lindeman NI; Department of Pathology, Weill Cornell Medicine, New York, NY., Lindsley RC; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lovitch SB; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Luskin MR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Nowak A; Department of Performance Improvement, Stanford Medicine Children's Health, Stanford, CA., Petrides A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Enterprise Research IS (ERIS), Digital, Mass General Brigham, Boston, MA., Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Steensma DP; Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA., Stone RM; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Weinberg OK; Department of Pathology, UT Southwestern Medical Center, Dallas, TX., Winer ES; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Feb; Vol. 20 (2), pp. 220-227. Date of Electronic Publication: 2023 Sep 08.

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Autor: Hines MR; Department of Pediatric Medicine, Division of Critical Care, St. Jude Children's Research Hospital, Memphis, Tennessee., Knight TE; Pediatric Hematology and Oncology, Seattle Children's Hospital and the University of Washington School of Medicine, Seattle, Washington., McNerney KO; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida., Leick MB; Cellular Immunotherapy Program and Blood and Marrow Transplant Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Jain T; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland., Ahmed S; Departments of Lymphoma and Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas., Frigault MJ; Cellular Immunotherapy Program and Blood and Marrow Transplant Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Hill JA; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington., Jain MD; Moffitt Cancer Center, Tampa, Florida., Johnson WT; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York., Lin Y; Division Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, Minnesota., Mahadeo KM; Pediatric Transplantation and Cellular Therapy, Duke University, Durham, North Carolina., Maron GM; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, and Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee., Marsh RA; University of Cincinnati, and Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Neelapu SS; Departments of Lymphoma and Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nikiforow S; Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Ombrello AK; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland., Shah NN; Bone Marrow Transplant and Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Talleur AC; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee and Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee., Turicek D; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Vatsayan A; Division of Blood and Marrow Transplantation, Children's National Health System, Washington, District of Columbia., Wong SW; UCSF Health Division of Hematology and Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Maus MV; Cellular Immunotherapy Program and Blood and Marrow Transplant Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Komanduri KV; UCSF Health Division of Hematology and Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Berliner N; Brigham and Women's Hospital, Boston, Massachusetts., Henter JI; Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institute, and Department of Paediatric Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York., Frey NV; Division of Hematology-Oncology, Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Teachey DT; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: Nirali.Shah@nih.gov.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jul; Vol. 29 (7), pp. 438.e1-438.e16. Date of Electronic Publication: 2023 Mar 09.